Maxcyte (MXCT) Accumulated Depreciation & Amortization (2020 - 2025)
Historic Accumulated Depreciation & Amortization for Maxcyte (MXCT) over the last 6 years, with Q3 2025 value amounting to -$3.8 million.
- Maxcyte's Accumulated Depreciation & Amortization rose 3857.37% to -$3.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$3.8 million, marking a year-over-year increase of 3857.37%. This contributed to the annual value of -$5.0 million for FY2024, which is 4378.6% up from last year.
- As of Q3 2025, Maxcyte's Accumulated Depreciation & Amortization stood at -$3.8 million, which was up 3857.37% from -$4.6 million recorded in Q2 2025.
- In the past 5 years, Maxcyte's Accumulated Depreciation & Amortization ranged from a high of -$1.8 million in Q2 2021 and a low of -$10.6 million during Q1 2023
- Its 5-year average for Accumulated Depreciation & Amortization is -$6.7 million, with a median of -$7.1 million in 2022.
- In the last 5 years, Maxcyte's Accumulated Depreciation & Amortization crashed by 43978.49% in 2022 and then skyrocketed by 4378.6% in 2024.
- Quarter analysis of 5 years shows Maxcyte's Accumulated Depreciation & Amortization stood at -$2.8 million in 2021, then tumbled by 244.42% to -$9.5 million in 2022, then rose by 7.03% to -$8.9 million in 2023, then soared by 43.79% to -$5.0 million in 2024, then increased by 23.03% to -$3.8 million in 2025.
- Its Accumulated Depreciation & Amortization stands at -$3.8 million for Q3 2025, versus -$4.6 million for Q2 2025 and -$5.2 million for Q1 2025.